Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
EPIX Essa Pharma Inc
- Stocks
- Healthcare
- NASDAQ: EPIX
Price (delayed)
$1.72
Market cap
$76.35M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.63
Enterprise value
-$9.68M
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in
Highlights
EPIX's quick ratio has surged by 104% year-on-year and by 103% since the previous quarter
The company's debt fell by 21% YoY and by 8% QoQ
The net income has grown by 8% from the previous quarter but it has contracted by 2.7% YoY
EPIX's equity is down by 15% year-on-year and by 4.4% since the previous quarter
Key stats
What are the main financial stats of EPIX
Market
Valuations
Earnings
Shares outstanding
44.39M
Market cap
$76.35M
Enterprise value
-$9.68M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$33.4M
Net income
-$28.5M
EBIT
-$28.5M
EBITDA
-$28.4M
Free cash flow
-$22.43M
Per share
Balance sheet
Liquidity
EPS
-$0.63
EPS diluted
-$0.63
Free cash flow per share
-$0.51
Book value per share
$2.56
Revenue per share
$0
TBVPS
$2.6
Total assets
$115.42M
Total liabilities
$1.87M
Debt
$280,201
Equity
$113.55M
Working capital
$113.45M
Debt to equity
0
Current ratio
67.17
Quick ratio
66.65
Net debt/EBITDA
3.03
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-22.9%
Return on equity
-23.5%
Return on invested capital
-96.8%
Return on capital employed
-25.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EPIX stock price
How has the Essa Pharma stock price performed over time
Intraday
2.99%
1 week
-0.58%
1 month
4.24%
1 year
-71.33%
YTD
-3.91%
QTD
8.86%
Financial performance
How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.4M
Net income
-$28.5M
Gross margin
N/A
Net margin
N/A
EPIX's operating income is up by 9% since the previous quarter and by 2.2% year-on-year
The net income has grown by 8% from the previous quarter but it has contracted by 2.7% YoY
Price vs fundamentals
How does EPIX's price correlate with its fundamentals
Growth
What is Essa Pharma's growth rate over time
Valuation
What is Essa Pharma stock price valuation
P/E
N/A
P/B
0.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 9% QoQ
The stock's price to book (P/B) is 68% less than its 5-year quarterly average of 2.1 and 48% less than its last 4 quarters average of 1.3
EPIX's equity is down by 15% year-on-year and by 4.4% since the previous quarter
Efficiency
How efficient is Essa Pharma business performance
EPIX's ROE is down by 21% YoY but it is up by 4.5% from the previous quarter
EPIX's return on assets is down by 21% year-on-year but it is up by 4.2% since the previous quarter
EPIX's return on invested capital is down by 2.9% since the previous quarter
Dividends
What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EPIX.
Financial health
How did Essa Pharma financials performed over time
The company's current ratio has surged by 104% YoY and by 103% QoQ
EPIX's quick ratio has surged by 104% year-on-year and by 103% since the previous quarter
The company's debt is 100% lower than its equity
The company's debt fell by 21% YoY and by 8% QoQ
EPIX's equity is down by 15% year-on-year and by 4.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.